SLC33A1 and proteostasis deficiencies: We also show that these ATase inhibitors can rescue disease manifestations associated with the progeria-like phenotype of AT-1 sTg mice, as well as the proteopathy of the Alzheimer’s disease (AD)-like phenotype of APP/PS1 mice.